Cargando...
Residual inflammatory risk after contemporary lipid lowering therapy
BACKGROUND: Recently, there has been an increasing interest in targeting inflammation to reduce major adverse cardiovascular events (MACE) in patients with cardiovascular risk. Statins, PCSK9 inhibitors, and ezetimibe have been shown to reduce MACE owing to reduction in low-density lipoproteins chol...
Gardado en:
| Publicado en: | Eur Heart J Qual Care Clin Outcomes |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7850089/ https://ncbi.nlm.nih.gov/pubmed/31609450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjqcco/qcz055 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|